Vaccine candidates are being offered through an Emergency Use Authorization by the Food and Drug Administration. Getting the vaccine protects yourself, your family, your community and our nation.
The Department of Defense is implementing a standardized and coordinated strategy for prioritizing, distributing, and administering a COVID-19 vaccine(s) through a phased approach to DoD uniformed service members, both the active and Selected Reserve components, including members of the National Guard; dependents; retirees; civilian employees, and selected DoD contract personnel as authorized in accordance with DoD regulation.
The Department’s priorities are:
- Protecting our Service members, DoD civilians, and families
- Safeguarding our national security capabilities
- Supporting the whole-of-nation response to the COVID-19 pandemic
COVID-19 Vaccine Toolkit PageTRICARE Beneficiary Information
About the COVID-19 Vaccine
COVID-19 vaccines are being developed as quickly as possible and we understand there may be concerns, but processes and procedures are in place to ensure the safety of any vaccine that is authorized for use. Vaccine(s) for COVID-19 are only available after they are:
- Demonstrated to be safe and effective in large phase three clinical trials
- Authorized by the U.S. Food and Drug Administration
- Manufactured and distributed safely and securely
Visit the Centers for Disease Control and Prevention to learn more about the COVID-19 vaccine.
SecDef COVID-19 Vaccine Message
You also may be interested in...
Article
3/5/2021
Beck’s arrival signals a new phase of Fort Carson’s COVID-19 vaccination efforts for TRICARE beneficiaries 75 and older.
Recommended Content:
Coronavirus | COVID-19 Vaccine Efforts
Infographic
3/5/2021
This Infographic informs TRICARE beneficiaries which tier they fall into as their local military treatment facility or clinic offers the vaccine.
Recommended Content:
Coronavirus | COVID-19 Vaccine Efforts
Article
2/23/2021
Five DoD sites across the United States will be part of the STORM CHASER trial, a study to observe the efficacy of a long-lasting antibody product to prevent COVID-19 among people who have been exposed to others suffering from the disease.
Recommended Content:
Coronavirus | COVID-19 Vaccine Efforts | COVID-19 Vaccine Toolkit
Showing results 1 - 15
Page 1 of 5